Filed in archive
Ethics
by leon on October 2, 2007
Drugs giant Bristol-Meyers Squibb and a former subsidiary have been hauled over the coals and forced to pay more than half a billion dollars to settle settle federal and state investigations for promoting an anti-psychotic drug, Ablify, for uses that were not approved by the US Food and Drug Administration and providing illegal inducements to doctors and other health care providers.
The inducements included consulting fees and all expenses paid trips to resorts to attend conferences. There were also allegations that Bristol-Myers Squibb was behind the submission of false or fraudulent claims to medicaid, Medicare and other federal health programs.
You can read more about it in the news report from the Boston Herald or you can check the detail in the settlement agreement here.
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/94420
Addthis
Ask
Blinklist
del.icio.us
Digg
Fark
Facebook
Google
Lycos
Ma.gnolia
Mr Wong
Netscape
Netvousz
Newsvine
Reddit
StumbleUpon
Slashdot
Tailrank
Technorati
Wink
Yahoo
Vote for Bristol-Myers Squibb pinged $515 million to settle fraud charges:
|
Rating: 8.67 out of 3 vote(s) cast.
|
Subscribe
Use the search to look for other interesting posts
| RSS |  See all blog subscribe options |
 What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |
